| 18.46 0.79 (4.47%) | 06-05 16:00 | |||||||||||||
|
|
| Short term | ||||
| Mid term | ||||
| Targets | 6-month : | 23.18 | 1-year : | 24.85 |
| Resists | First : | 19.84 | Second : | 21.28 |
| Pivot price | 19.89 |
|||
| Supports | First : | 17.53 | Second : | 14.58 |
| MAs | MA(5) : | 18.36 |
MA(20) : | 20.07 |
| MA(100) : | 19.65 |
MA(250) : | 18.52 |
|
| MACD | MACD : | -0.5 |
Signal : | -0.2 |
| %K %D | K(14,3) : | 9.7 |
D(3) : | 4.6 |
| RSI | RSI(14): 34.2 |
|||
| 52-week | High : | 21.28 | Low : | 16.4 |
Price has closed above its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.[ SBRA ] has closed above bottom band by 18.7%. Bollinger Bands are 183.5% wider than normal. The large width of the bands suggest high volatility as compared to its normal range. The bands have been in this wide range for 3 days. This is a sign that the current trend might continue.
| If tomorrow: | Open lower | Open higher |
| High: | 18.59 - 18.72 | 18.72 - 18.83 |
| Low: | 17.31 - 17.47 | 17.47 - 17.6 |
| Close: | 18.22 - 18.46 | 18.46 - 18.69 |
As of March 31, 2022, Sabra's investment portfolio included 416 real estate properties held for investment. This consists of (i) 279 Skilled Nursing/Transitional Care facilities, (ii) 59 Senior Housing communities (Senior Housing - Leased), (iii) 50 Senior Housing communities operated by third-party property managers pursuant to property management agreements (Senior Housing - Managed), (iv) 13 Behavioral Health facilities and (v) 15 Specialty Hospitals and Other facilities), one asset held for sale, one investment in a sales-type lease, 16 investments in loans receivable (consisting of (i) two mortgage loans, (ii) one construction loan and (iii) 13 other loans), seven preferred equity investments and one investment in an unconsolidated joint venture. As of March 31, 2022, Sabra's real estate properties held for investment included 41,445 beds/units, spread across the United States and Canada.
Fri, 05 Jun 2026
Sabra Health Care REIT Stock Plummets 15% With 7-Day Losing Streak - Trefis
Fri, 05 Jun 2026
Sabra Health Care REIT Stock Slides -15% With A 7-Day Losing Spree - Trefis
Wed, 03 Jun 2026
Assessing Sabra Health Care REIT (SBRA) Valuation After Recent Share Price Weakness - simplywall.st
Tue, 02 Jun 2026
How The Sabra Health Care REIT (SBRA) Investment Story Is Evolving With Recent Updates - Yahoo Finance
Tue, 02 Jun 2026
Sabra Health Care REIT (SBRA) director receives 817 stock units grant - Stock Titan
Tue, 02 Jun 2026
Sabra Health Care (SBRA) director gifts shares and receives stock units - Stock Titan
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Underperform |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Outperform |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Outperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Neutral |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Underperform |
|
Exchange:
NASDAQ
|
|
|
Sector:
Real Estate
|
|
|
Industry:
REIT - Healthcare Facilities
|
|
| Shares Out | 252 (M) |
| Shares Float | 249 (M) |
| Held by Insiders | 1.4 (%) |
| Held by Institutions | 108 (%) |
| Shares Short | 31,370 (K) |
| Shares Short P.Month | 27,780 (K) |
| EPS | 0.62 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 11.05 |
| Profit Margin | 19.1 % |
| Operating Margin | 31.4 % |
| Return on Assets (ttm) | 3 % |
| Return on Equity (ttm) | 5.6 % |
| Qtrly Rev. Growth | 21.7 % |
| Gross Profit (p.s.) | 2.06 |
| Sales Per Share | 3.23 |
| EBITDA (p.s.) | 1.82 |
| Qtrly Earnings Growth | -5.6 % |
| Operating Cash Flow | 367 (M) |
| Levered Free Cash Flow | 198 (M) |
| PE Ratio | 29.3 |
| PEG Ratio | 5.2 |
| Price to Book value | 1.67 |
| Price to Sales | 5.7 |
| Price to Cash Flow | 12.69 |
| Dividend | 0.3 |
| Forward Dividend | 0 |
| Dividend Yield | 1.6% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |